Oral okt3    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
97Ulcerative colitis1

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,269 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01287195
(ClinicalTrials.gov)
April 7, 201128/1/2011Oral OKT3 for the Treatment of Active Ulcerative ColitisOral Anti-CD3 for the Treatment of Active Ulcerative ColitisUlcerative ColitisDrug: Oral OKT3;Drug: OmeprazoleBrigham and Women's HospitalNULLCompleted18 Years65 YearsAll6Phase 1;Phase 2United States